|
MechanismTubulin inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1995 |
100 Clinical Results associated with Ar Holding Co., Inc.
0 Patents (Medical) associated with Ar Holding Co., Inc.
100 Deals associated with Ar Holding Co., Inc.
100 Translational Medicine associated with Ar Holding Co., Inc.